SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000882104-19-000046
Filing Date
2019-04-30
Accepted
2019-04-30 17:14:34
Documents
5
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A pdli-20180426defa14adoc.htm DEFA14A 33248
2 a2019card1.jpg GRAPHIC 137114
3 a2019card2.jpg GRAPHIC 231671
4 a2019card3.jpg GRAPHIC 66160
5 a2019card4.jpg GRAPHIC 17939
  Complete submission text file 0000882104-19-000046.txt   636801
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19756 | Film No.: 19783128
SIC: 2836 Biological Products, (No Diagnostic Substances)